APA (7th ed.) Citation

S, H., F, A. d. S., SM, Z., M, K., HA, K., N, F., & AV, K. (2025). Progression of QRS duration - a potential surrogate marker of survival in ATTRwt amyloidosis patients. Orphanet journal of rare diseases, 20(1), 523. https://doi.org/10.1186/s13023-025-04078-4

Chicago Style (17th ed.) Citation

S, Hein, Aus dem Siepen F, Zierleyn SM, Knoll M, Katus HA, Frey N, and Kristen AV. "Progression of QRS Duration - a Potential Surrogate Marker of Survival in ATTRwt Amyloidosis Patients." Orphanet Journal of Rare Diseases 20, no. 1 (2025): 523. https://doi.org/10.1186/s13023-025-04078-4.

MLA (9th ed.) Citation

S, Hein, et al. "Progression of QRS Duration - a Potential Surrogate Marker of Survival in ATTRwt Amyloidosis Patients." Orphanet Journal of Rare Diseases, vol. 20, no. 1, 2025, p. 523, https://doi.org/10.1186/s13023-025-04078-4.